Gynecologic Cancer News

In the final installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about which adults may derive the most benefit from catch-up HPV vaccination.

The proportion of women in the U.S. who were not up to date on recommended cervical cancer screening significantly increased from 2005 to 2019, according to findings published in JAMA Network Open.

In the third installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about how clinicians can help overcome HPV vaccine hesitancy.

Coffee consumption may reduce the risk for endometrial cancer, according to a study published in The Journal of Obstetrics and Gynaecology Research.

The COVID-19 pandemic could reverse improvements made in recent decades toward HPV vaccination efforts, according to Mona Saraiya, MD, MPH.

In the second installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the impact of HPV vaccination on the global burden of cervical cancer.

In the first installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the importance of HPV vaccination.

Individuals with an increased platelet count demonstrated an increased risk for cancer, with the association especially strong in colon, lung, ovarian and stomach cancers, according to a nested case-control study in JAMA Network Open.

Non-speculum sampling by clinicians and self-sampling “substantially increased” cervical cancer screening uptake in women aged 50 to 64 years who were overdue for screening, according to researchers.

The FDA cleared an investigational new drug application for FT536, a chimeric antigen receptor natural killer cell therapy designed to treat adults with certain relapsed or refractory solid tumors.